-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HzKjGH6G1v00UmIDueubzbQ6MSejiUwKsptflws4Eh0ZVInQzsrkZsVq4cCk4Xna A+cvm3hPOS/PVR8dgSkUDQ== 0001104659-09-021327.txt : 20090330 0001104659-09-021327.hdr.sgml : 20090330 20090330161117 ACCESSION NUMBER: 0001104659-09-021327 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20090330 DATE AS OF CHANGE: 20090330 GROUP MEMBERS: DANIEL J. DONOGHUE GROUP MEMBERS: DISCOVERY GROUP I, LLC GROUP MEMBERS: MICHAEL R. MURPHY SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DRUGSTORE COM INC CENTRAL INDEX KEY: 0001086467 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 043416255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-57797 FILM NUMBER: 09714322 BUSINESS ADDRESS: STREET 1: 411 108TH AVE. NE STREET 2: SUITE 1400 CITY: BELLEVUE STATE: WA ZIP: 98004 BUSINESS PHONE: 4253723200 MAIL ADDRESS: STREET 1: 411 108TH AVE. NE STREET 2: SUITE 1400 CITY: BELLEVUE STATE: WA ZIP: 98004 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DISCOVERY EQUITY PARTNERS, LP CENTRAL INDEX KEY: 0001258542 IRS NUMBER: 300075082 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: C/O DISCOVERY GROUP I, LLC STREET 2: 191 N. WACKER DRIVE SUITE 1685 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-265-9600 MAIL ADDRESS: STREET 1: C/O DISCOVERY GROUP I, LLC STREET 2: 191 N. WACKER DRIVE SUITE 1685 CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: DISCOVERY EQUITY PARTNERS LP DATE OF NAME CHANGE: 20030806 SC 13D/A 1 a09-8895_1sc13da.htm SC 13D/A

 

 

UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE COMMISSION

OMB Number:  3235-0145

 

Washington, D.C. 20549

 

 

 

Expires: February 28, 2009

 

SCHEDULE 13D

Estimated average burden hours per response. . 14.5

 

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

 

 

drugstore.com, inc.

(Name of Issuer)

 

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

 

262241102

(CUSIP Number)

 

Michael R. Murphy

Discovery Group I, LLC

191 North Wacker Drive

Suite 1685

Chicago, Illinois 60606

Telephone Number: (312) 265-9600

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

June 23, 2008

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 



 

CUSIP No.   262241102

 

 

1.

Names of Reporting Persons.
Discovery Equity Partners, L.P.

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
WC

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
Illinois

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
None.

 

8.

Shared Voting Power
6,224,631

 

9.

Sole Dispositive Power
None.

 

10.

Shared Dispositive Power
6,224,631

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
6,224,631

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
6.3%

 

 

14.

Type of Reporting Person (See Instructions)
PN

 

2



 

CUSIP No.   262241102

 

 

1.

Names of Reporting Persons.
Discovery Group I, LLC

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
AF

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
Delaware

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
None.

 

8.

Shared Voting Power
7,251,265

 

9.

Sole Dispositive Power
None.

 

10.

Shared Dispositive Power
7,251,265

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
7,251,265

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
7.3%

 

 

14.

Type of Reporting Person (See Instructions)
OO

 

3



 

CUSIP No.   262241102

 

 

1.

Names of Reporting Persons.
Daniel J. Donoghue

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
AF

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
United States of America

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
None.

 

8.

Shared Voting Power
7,251,265

 

9.

Sole Dispositive Power
None.

 

10.

Shared Dispositive Power
7,251,265

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
7,251,265

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
7.3%

 

 

14.

Type of Reporting Person (See Instructions)
IN

 

4



 

CUSIP No.   262241102

 

 

1.

Names of Reporting Persons.
Michael R. Murphy

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 o

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
AF

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
United States of America

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
None.

 

8.

Shared Voting Power
7,251,265

 

9.

Sole Dispositive Power
None.

 

10.

Shared Dispositive Power
7,251,265

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
7,251,265

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
7.3%

 

 

14.

Type of Reporting Person (See Instructions)
IN

 

5



 

Item 1.

Security and Issuer

 

This Amendment No. 1 to Schedule 13D (“Amendment No. 1”) relates to the Common Stock, $0.0001 par value per share (the “Common Stock”), of drugstore.com, inc., a Delaware corporation (the “Company”), which has its principal executive offices at 411 108th Avenue NE, Suite 1400, Bellevue, WA 98004.  This Amendment No. 1 amends and supplements, as set forth below, the information contained in items 1, 2, 3, 5 and 6 of the Schedule 13D filed by the Reporting Persons with respect to the Company on February 19, 2008 (as so amended, the “Schedule 13D”).  All capitalized terms used herein but not defined herein have the meanings set forth in the Schedule 13D.  Except as amended by this Amendment No. 1, all information contained in the Schedule 13D is, after reasonable inquiry and to the best of the Reporting Persons’ knowledge and belief, true, complete and correct as of the date of this Amendment No. 1.

 

 

Item 2.

Identity and Background

 

Item 2 of the Schedule 13D is hereby amended by adding the following as the second line thereof:

 

Discovery Equity Partners, L.P. (“Discovery Equity Partners”) is an Illinois limited partnership primarily engaged in the business of investing in securities.

 

 

Item 3.

Source and Amount of Funds or Other Consideration

 

Item 3 of the Schedule 13D is hereby amended to read in its entirety as follows:

 

The total purchase price for the 7,251,265 shares of Common Stock beneficially owned by Discovery Group and Messrs. Donoghue and Murphy as of March 27, 2009 was approximately $19,033,465, and the total purchase price for the 6,224,631 shares of Common Stock beneficially owned by Discovery Equity Partners was approximately $16,338,723.  The source of such funds was the assets of Discovery Equity Partners and another private investment partnership (collectively, the “Partnerships”) over which Discovery Group exercises discretionary investment management authority, including proceeds of margin loans under margin loan facilities maintained in the ordinary course of business by the Partnerships with a broker on customary terms and conditions.  The Partnerships are the legal owner of all of the Common Stock beneficially owned by Discovery Group and Messrs. Donoghue and Murphy.

 

 

Item 5.

Interest in Securities of the Issuer

 

Item 5 of the Schedule 13D is hereby amended to read in its entirety as follows:

 

The information concerning percentages of ownership set forth below is based on 99,531,469 shares of Common Stock reported outstanding as of March 5, 2009 in the Company’s most recent Annual Report on Form 10-K, for the period ended December 28, 2008.

 

Discovery Equity Partners beneficially owns 6,224,631 shares of Common Stock as of March 27, 2009, which represents 6.3% of the outstanding Common Stock.

 

Discovery Group beneficially owns 7,251,265 shares of Common Stock as of March 27, 2009, which represents 7.3% of the outstanding Common Stock.

 

Mr. Donoghue beneficially owns 7,251,265 shares of Common Stock as of March 27, 2009, which

 

6



 

 

represents 7.3% of the outstanding Common Stock.

 

Mr. Murphy beneficially owns 7,251,265 shares of Common Stock as of March 27, 2009, which represents 7.3% of the outstanding Common Stock.

 

Discovery Group is the sole general partner of one of the Partnerships and has sole discretionary investment authority with respect to the other Partnership’s investment in the Common Stock.  Messrs. Donoghue and Murphy are the sole managing members of Discovery Group.  As a consequence, Discovery Group and Messrs. Donoghue and Murphy may be deemed to share beneficial ownership of all of the shares of Common Stock owned by both of the Partnerships.

 

The transactions in Common Stock effected by the Reporting Persons during the past 60 days are set out in Exhibit 1 hereto.

 

No person other than the Partnerships is known to any Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any of the shares of Common Stock reported herein. 

 

 

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

 

Item 6 of the Schedule 13D is hereby amended to read in its entirety as follows:

 

There are no contracts, arrangements, understandings or relationships (legal or otherwise) between or among any of the Reporting Persons and any other person with respect to any securities of the Company other than the governing documents of Discovery Group and the Partnerships, the margin loan facilities referred to under Item 3 above, the Joint Filing Agreement of the Reporting Persons with respect to the Schedule 13D that was included as an exhibit thereto, the Joint Filing Agreement of the Reporting Persons with respect to this Amendment No. 1 included as Exhibit 2 to this Amendment No. 1, and the Powers of Attorney granted by Messrs Donoghue and Murphy with respect to reports under Section 13 of the Securities Exchange Act of 1934, as amended, which Powers of Attorney are included as Exhibit 3 and Exhibit 4, respectively, to this Amendment No. 1.

 

 

Item 7.

Material to be Filed as Exhibits

 

Exhibit 1:                List of transactions by Reporting Persons in the Company’s Common Stock during the past 60 days.

 

Exhibit 2:                Joint Filing Agreement dated as of March 30, 2009, by and among Discovery Equity Partners; Discovery Group; Daniel J. Donoghue; and Michael R. Murphy.

 

Exhibit 3:                Power of Attorney of Daniel J. Donoghue, dated as of April 28, 2008.

 

Exhibit 4:                Power of Attorney of Michael R. Murphy, dated as of April 28, 2008.

 

7



 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

March 30, 2009

 

Date

 

 

 

 

 

DISCOVERY GROUP I, LLC,

for itself and as general partner of

DISCOVERY EQUITY PARTNERS, L.P.

 

 

 

 

 

By:  Michael R. Murphy*

 

Signature

 


Michael R. Murphy, Managing Member

 

Name/Title

 



Daniel J. Donoghue*

 

Signature

 


Daniel J. Donoghue

 

Name/Title

 



Michael R. Murphy*

 

Signature

 


Michael R. Murphy

 

Name/Title

 

 

 

 

 

*By: /s/ Mark Buckley

 

Mark Buckley

 

Attorney-in-Fact for Daniel J. Donoghue
Attorney-in-Fact for Michael R. Murphy

 

8



 

Exhibit Index

 

Exhibit 1

List of transactions by Reporting Persons in the Company’s Common Stock during the past 60 days.

 

 

Exhibit 2

Joint Filing Agreement dated as of March 30, 2009, by and among Discovery Equity Partners; Discovery Group; Daniel J. Donoghue; and Michael R. Murphy.

 

 

Exhibit 3

Power of Attorney of Daniel J. Donoghue, dated as of April 28, 2008.

 

 

Exhibit 4

Power of Attorney of Michael R. Murphy, dated as of April 28, 2008.

 

9


EX-1 2 a09-8895_1ex1.htm EX-1

EXHIBIT 1

 

TRANSACTIONS DURING THE PAST 60 DAYS

 

The Reporting Persons engaged in the following transactions in shares of Common Stock of the Company during the past 60 days.  Such transactions involved the purchase of shares on the Nasdaq National Market System.

 

Date

 

Type

 

Price

 

Shares

 

1/30/2009

 

Purchase

 

$

0.90

 

5000

 

2/23/2009

 

Purchase

 

0.86

 

5000

 

2/23/2009

 

Purchase

 

0.87

 

2500

 

2/23/2009

 

Purchase

 

0.88

 

20000

 

2/23/2009

 

Purchase

 

0.90

 

2500

 

2/24/2009

 

Purchase

 

0.90

 

19200

 

2/25/2009

 

Purchase

 

0.8601

 

1500

 

2/25/2009

 

Purchase

 

0.87

 

1200

 

2/25/2009

 

Purchase

 

0.88

 

2000

 

2/25/2009

 

Purchase

 

0.89

 

4500

 

2/25/2009

 

Purchase

 

0.90

 

5000

 

2/26/2009

 

Purchase

 

0.87

 

881

 

2/26/2009

 

Purchase

 

0.88

 

7500

 

2/26/2009

 

Purchase

 

0.89

 

7998

 

2/26/2009

 

Purchase

 

0.895

 

200

 

2/26/2009

 

Purchase

 

0.8998

 

300

 

2/26/2009

 

Purchase

 

0.90

 

2100

 

2/27/2009

 

Purchase

 

0.8614

 

2900

 

2/27/2009

 

Purchase

 

0.88

 

10000

 

2/27/2009

 

Purchase

 

0.89

 

12500

 

2/27/2009

 

Purchase

 

0.90

 

10000

 

3/2/2009

 

Purchase

 

0.80

 

6479

 

3/2/2009

 

Purchase

 

0.8002

 

400

 

3/2/2009

 

Purchase

 

0.8003

 

2100

 

3/2/2009

 

Purchase

 

0.8006

 

6100

 

3/2/2009

 

Purchase

 

0.801

 

9000

 

3/2/2009

 

Purchase

 

0.8018

 

700

 

3/2/2009

 

Purchase

 

0.8024

 

100

 

3/2/2009

 

Purchase

 

0.8066

 

100

 

3/2/2009

 

Purchase

 

0.81

 

5100

 

3/2/2009

 

Purchase

 

0.8101

 

6617

 

3/2/2009

 

Purchase

 

0.8102

 

1200

 

3/2/2009

 

Purchase

 

0.8103

 

100

 

3/2/2009

 

Purchase

 

0.8105

 

100

 

3/2/2009

 

Purchase

 

0.8108

 

300

 

3/2/2009

 

Purchase

 

0.8119

 

800

 

3/2/2009

 

Purchase

 

0.8121

 

100

 

3/2/2009

 

Purchase

 

0.8125

 

200

 

 



 

Date

 

Type

 

Price

 

Shares

 

3/2/2009

 

Purchase

 

$

0.8131

 

100

 

3/2/2009

 

Purchase

 

0.8145

 

100

 

3/2/2009

 

Purchase

 

0.8148

 

1500

 

3/2/2009

 

Purchase

 

0.815

 

100

 

3/2/2009

 

Purchase

 

0.8151

 

100

 

3/3/2009

 

Purchase

 

0.74

 

200

 

3/3/2009

 

Purchase

 

0.7425

 

100

 

3/3/2009

 

Purchase

 

0.7449

 

100

 

3/3/2009

 

Purchase

 

0.75

 

10800

 

3/3/2009

 

Purchase

 

0.7525

 

100

 

3/3/2009

 

Purchase

 

0.755

 

1600

 

3/3/2009

 

Purchase

 

0.7599

 

944

 

3/3/2009

 

Purchase

 

0.76

 

300

 

3/3/2009

 

Purchase

 

0.77

 

5400

 

3/3/2009

 

Purchase

 

0.7705

 

100

 

3/3/2009

 

Purchase

 

0.7725

 

300

 

3/3/2009

 

Purchase

 

0.775

 

5056

 

3/3/2009

 

Purchase

 

0.78

 

5500

 

3/3/2009

 

Purchase

 

0.781

 

300

 

3/3/2009

 

Purchase

 

0.7825

 

200

 

3/3/2009

 

Purchase

 

0.785

 

333

 

3/3/2009

 

Purchase

 

0.7851

 

1495

 

3/3/2009

 

Purchase

 

0.7863

 

200

 

3/3/2009

 

Purchase

 

0.7876

 

3805

 

3/3/2009

 

Purchase

 

0.7888

 

300

 

3/3/2009

 

Purchase

 

0.79

 

3767

 

3/3/2009

 

Purchase

 

0.7903

 

1000

 

3/3/2009

 

Purchase

 

0.795

 

2500

 

3/3/2009

 

Purchase

 

0.80

 

2500

 

3/3/2009

 

Purchase

 

0.82

 

1000

 

3/4/2009

 

Purchase

 

0.84

 

800

 

3/4/2009

 

Purchase

 

0.8497

 

100

 

3/4/2009

 

Purchase

 

0.85

 

44100

 

3/4/2009

 

Purchase

 

0.8599

 

2789

 

3/4/2009

 

Purchase

 

0.86

 

7211

 

3/4/2009

 

Purchase

 

0.8601

 

200

 

3/5/2009

 

Purchase

 

0.7601

 

3529

 

3/5/2009

 

Purchase

 

0.77

 

5000

 

3/5/2009

 

Purchase

 

0.7701

 

5000

 

3/5/2009

 

Purchase

 

0.7726

 

5000

 

3/5/2009

 

Purchase

 

0.78

 

10000

 

3/5/2009

 

Purchase

 

0.79

 

200

 

3/5/2009

 

Purchase

 

0.7929

 

100

 

3/5/2009

 

Purchase

 

0.80

 

5000

 

3/5/2009

 

Purchase

 

0.81

 

5000

 

3/5/2009

 

Purchase

 

0.8194

 

100

 

 



 

Date

 

Type

 

Price

 

Shares

 

3/5/2009

 

Purchase

 

$

0.8195

 

1622

 

3/5/2009

 

Purchase

 

0.82

 

200

 

3/5/2009

 

Purchase

 

0.8201

 

10100

 

3/5/2009

 

Purchase

 

0.8204

 

100

 

3/5/2009

 

Purchase

 

0.8208

 

100

 

3/5/2009

 

Purchase

 

0.8216

 

700

 

3/5/2009

 

Purchase

 

0.8217

 

100

 

3/5/2009

 

Purchase

 

0.822

 

100

 

3/5/2009

 

Purchase

 

0.8226

 

200

 

3/5/2009

 

Purchase

 

0.8238

 

400

 

3/5/2009

 

Purchase

 

0.8244

 

100

 

3/5/2009

 

Purchase

 

0.8245

 

100

 

3/5/2009

 

Purchase

 

0.825

 

500

 

3/5/2009

 

Purchase

 

0.8251

 

100

 

3/5/2009

 

Purchase

 

0.8263

 

100

 

3/5/2009

 

Purchase

 

0.83

 

800

 

3/6/2009

 

Purchase

 

0.76

 

5439

 

3/6/2009

 

Purchase

 

0.7802

 

5000

 

3/6/2009

 

Purchase

 

0.80

 

16700

 

3/6/2009

 

Purchase

 

0.8001

 

3600

 

3/6/2009

 

Purchase

 

0.805

 

300

 

3/6/2009

 

Purchase

 

0.8051

 

9100

 

3/6/2009

 

Purchase

 

0.82

 

13540

 

3/6/2009

 

Purchase

 

0.84

 

100

 

3/6/2009

 

Purchase

 

0.845

 

100

 

3/6/2009

 

Purchase

 

0.85

 

650

 

3/6/2009

 

Purchase

 

0.855

 

667

 

3/6/2009

 

Purchase

 

0.8559

 

100

 

3/6/2009

 

Purchase

 

0.8575

 

400

 

3/6/2009

 

Purchase

 

0.86

 

10176

 

3/6/2009

 

Purchase

 

0.8601

 

256

 

3/6/2009

 

Purchase

 

0.865

 

5473

 

3/6/2009

 

Purchase

 

0.8651

 

600

 

3/6/2009

 

Purchase

 

0.8686

 

100

 

3/6/2009

 

Purchase

 

0.8699

 

300

 

3/6/2009

 

Purchase

 

0.87

 

1628

 

3/9/2009

 

Purchase

 

0.80

 

7344

 

3/9/2009

 

Purchase

 

0.81

 

5000

 

3/9/2009

 

Purchase

 

0.815

 

1000

 

3/9/2009

 

Purchase

 

0.82

 

10000

 

3/9/2009

 

Purchase

 

0.83

 

24

 

3/9/2009

 

Purchase

 

0.8417

 

200

 

3/9/2009

 

Purchase

 

0.8418

 

5076

 

3/10/2009

 

Purchase

 

0.84

 

4700

 

3/10/2009

 

Purchase

 

0.841

 

300

 

3/10/2009

 

Purchase

 

0.85

 

11200

 

 



 

Date

 

Type

 

Price

 

Shares

 

3/10/2009

 

Purchase

 

$

0.853

 

86

 

3/10/2009

 

Purchase

 

0.86

 

10300

 

3/10/2009

 

Purchase

 

0.8603

 

100

 

3/10/2009

 

Purchase

 

0.8605

 

300

 

3/10/2009

 

Purchase

 

0.8606

 

1300

 

3/10/2009

 

Purchase

 

0.8612

 

100

 

3/10/2009

 

Purchase

 

0.862

 

100

 

3/10/2009

 

Purchase

 

0.8623

 

400

 

3/10/2009

 

Purchase

 

0.8624

 

100

 

3/10/2009

 

Purchase

 

0.8625

 

100

 

3/10/2009

 

Purchase

 

0.8627

 

100

 

3/10/2009

 

Purchase

 

0.8636

 

100

 

3/10/2009

 

Purchase

 

0.8641

 

100

 

3/10/2009

 

Purchase

 

0.8647

 

500

 

3/10/2009

 

Purchase

 

0.865

 

700

 

3/10/2009

 

Purchase

 

0.8654

 

400

 

3/10/2009

 

Purchase

 

0.87

 

9722

 

3/10/2009

 

Purchase

 

0.88

 

2000

 

3/10/2009

 

Purchase

 

0.89

 

1000

 

3/10/2009

 

Purchase

 

0.90

 

1000

 

3/11/2009

 

Purchase

 

0.85

 

400

 

3/11/2009

 

Purchase

 

0.86

 

11200

 

3/11/2009

 

Purchase

 

0.88

 

48686

 

3/11/2009

 

Purchase

 

0.90

 

10000

 

3/12/2009

 

Purchase

 

0.84

 

100

 

3/12/2009

 

Purchase

 

0.85

 

2000

 

3/12/2009

 

Purchase

 

0.88

 

1200

 

3/12/2009

 

Purchase

 

0.90

 

2000

 

 


EX-2 3 a09-8895_1ex2.htm EX-2

EXHIBIT 2

 

JOINT FILING AGREEMENT

 

The undersigned hereby agree to the joint filing of Amendment No. 1 to the Schedule 13D to which this Agreement is attached.

 

Dated:  March 30, 2009

 

 

DISCOVERY GROUP I, LLC

 

 

for itself and as general partner of

 

 

DISCOVERY EQUITY PARTNERS, L.P.

 

 

 

 

 

 

 

By

Michael R. Murphy*

 

 

Michael R. Murphy

 

 

Managing Member

 

 

 

 

 

 

 

Daniel J. Donoghue*

 

Daniel J. Donoghue

 

 

 

 

 

 

 

Michael R. Murphy*

 

Michael R. Murphy

 

 

 

 

 

 

 

*By:

 /s/ Mark Buckley

 

 

 Mark Buckley

 

 

Attorney-in-Fact for Daniel J. Donoghue

 

 

Attorney-in-Fact for Michael R. Murphy

 


EX-3 4 a09-8895_1ex3.htm EX-3

EXHIBIT 3

 

POWER OF ATTORNEY

 

The undersigned, Daniel J. Donoghue, hereby appoints Mark Buckley his true and lawful attorney-in-fact and agent, with full power to execute and file with the United States Securities and Exchange Commission and any stock exchange or similar authority, for and on his behalf in any and all capacities, any and all reports required to be filed pursuant to Section 13 of the Securities Exchange Act of 1934 and the rules thereunder on Schedule 13D or 13G, any and all amendments to such reports, with all exhibits, and any other forms or documents as may be necessary in connection with the filing of such reports with the United States Securities and Exchange Commission and any stock exchange or similar authority, granting unto said attorney full power and authority to do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete, as fully as the undersigned might or could do in person.

 

This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact and agent.

 

IN WITNESS WHEREOF the undersigned has caused this Power of Attorney to be executed this 28th day of April, 2008.

 

 

 

/s/ Daniel J. Donoghue

 

Daniel J. Donoghue

 

 

STATE OF ILLINOIS

)

 

 

 

 

) SS.

 

 

 

COUNTY OF COOK

)

 

 

 

 

I, Kareema M. Cruz, a Notary Public in and for the County of Cook, State of Illinois, DO HEREBY CERTIFY that Daniel J. Donoghue, who is personally known to me to be the same person whose name is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he signed and delivered the said instrument as his own free and voluntary act, for the uses and purposes therein set forth.

 

Given under my hand and notarial seal, this 28th day of April, 2008.

 

 

 

/s/ Kareema M. Cruz

 

Notary Public

 


EX-4 5 a09-8895_1ex4.htm EX-4

EXHIBIT 4

 

POWER OF ATTORNEY

 

The undersigned, Michael R. Murphy, hereby appoints Mark Buckley his true and lawful attorney-in-fact and agent, with full power to execute and file with the United States Securities and Exchange Commission and any stock exchange or similar authority, for and on his behalf in any and all capacities, any and all reports required to be filed pursuant to Section 13 of the Securities Exchange Act of 1934 and the rules thereunder on Schedule 13D or 13G, any and all amendments to such reports, with all exhibits, and any other forms or documents as may be necessary in connection with the filing of such reports with the United States Securities and Exchange Commission and any stock exchange or similar authority, granting unto said attorney full power and authority to do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete, as fully as the undersigned might or could do in person.

 

This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact and agent.

 

IN WITNESS WHEREOF the undersigned has caused this Power of Attorney to be executed this 28th day of April, 2008.

 

 

 

/s/ Michael R. Murphy

 

Michael R. Murphy

 

 

STATE OF ILLINOIS

)

 

 

 

 

) SS.

 

 

 

COUNTY OF COOK

)

 

 

 

 

I, Kareema M. Cruz, a Notary Public in and for the County of Cook, State of Illinois, DO HEREBY CERTIFY that Michael R. Murphy, who is personally known to me to be the same person whose name is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he signed and delivered the said instrument as his own free and voluntary act, for the uses and purposes therein set forth.

 

Given under my hand and notarial seal, this 28th day of April, 2008.

 

 

/s/ Kareema M. Cruz

 

Notary Public

 


-----END PRIVACY-ENHANCED MESSAGE-----